OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Brain-derived neurotrophic factor and neurofilament light chain in cerebrospinal fluid are inversely correlated with cognition in Multiple Sclerosis at the time of diagnosis
Yavor Yalachkov, Victoria Anschütz, Jasmin Jakob, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 63, pp. 103822-103822
Closed Access | Times Cited: 13
Yavor Yalachkov, Victoria Anschütz, Jasmin Jakob, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 63, pp. 103822-103822
Closed Access | Times Cited: 13
Showing 13 citing articles:
A Brief Overview on BDNF-Trk Pathway in the Nervous System: A Potential Biomarker or Possible Target in Treatment of Multiple Sclerosis?
Giuseppe Schirò, Salvatore Iacono, Paolo Ragonese, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 43
Giuseppe Schirò, Salvatore Iacono, Paolo Ragonese, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 43
Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis
Kimberly Koerbel, Michelle Maiworm, Martin Schaller, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 87, pp. 105644-105644
Open Access | Times Cited: 8
Kimberly Koerbel, Michelle Maiworm, Martin Schaller, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 87, pp. 105644-105644
Open Access | Times Cited: 8
Cognitive Impairment in Multiple Sclerosis: An Update on Assessment and Management
Emilio Portaccio, Maria Pia Amato
NeuroSci (2022) Vol. 3, Iss. 4, pp. 667-676
Open Access | Times Cited: 36
Emilio Portaccio, Maria Pia Amato
NeuroSci (2022) Vol. 3, Iss. 4, pp. 667-676
Open Access | Times Cited: 36
Effect of Estimated Blood Volume and Body Mass Index on GFAP and NfL Levels in the Serum and CSF of Patients With Multiple Sclerosis
Yavor Yalachkov, Jan Hendrik Schäfer, Jasmin Jakob, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Yavor Yalachkov, Jan Hendrik Schäfer, Jasmin Jakob, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Molecular biomarkers and cognitive impairment in multiple sclerosis: State of the field, limitations, and future direction – A systematic review and meta-analysis
Tom-D. Rademacher, Sven G. Meuth, Heinz Wiendl, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105035-105035
Closed Access | Times Cited: 16
Tom-D. Rademacher, Sven G. Meuth, Heinz Wiendl, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105035-105035
Closed Access | Times Cited: 16
Identification and management of subclinical disease activity in early multiple sclerosis: a review
Daniel Ontaneda, Tanuja Chitnis, Kottil Rammohan, et al.
Journal of Neurology (2023) Vol. 271, Iss. 4, pp. 1497-1514
Open Access | Times Cited: 13
Daniel Ontaneda, Tanuja Chitnis, Kottil Rammohan, et al.
Journal of Neurology (2023) Vol. 271, Iss. 4, pp. 1497-1514
Open Access | Times Cited: 13
Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to serum and cerebrospinal fluid markers of neuroaxonal and glial injury
Martin Schaller, Michelle Maiworm, Jan Hendrik Schäfer, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3512-3526
Open Access | Times Cited: 5
Martin Schaller, Michelle Maiworm, Jan Hendrik Schäfer, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3512-3526
Open Access | Times Cited: 5
Cognitive impairment in multiple sclerosis: from phenomenology to neurobiological mechanisms
K. A. Jellinger
Journal of Neural Transmission (2024) Vol. 131, Iss. 8, pp. 871-899
Closed Access | Times Cited: 4
K. A. Jellinger
Journal of Neural Transmission (2024) Vol. 131, Iss. 8, pp. 871-899
Closed Access | Times Cited: 4
Exploring the Link Between Renal Function Fluctuations Within the Physiological Range and Serum/CSF Levels of NfL, GFAP, tTAU, and UCHL1
Kimberly Koerbel, Yavor Yalachkov, Thomas Rotter, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 748-748
Open Access
Kimberly Koerbel, Yavor Yalachkov, Thomas Rotter, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 748-748
Open Access
Cognitive Impairment in Newly Diagnosed Patients with Multiple Sclerosis: A Systematic Review of Related Molecular Biomarkers and a Meta-Analysis of Associated Demographic and Disease-Related Characteristics
Konstantina Stavrogianni, Vasileios Giannopapas, Dimitrios K. Kitsos, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2630-2630
Open Access
Konstantina Stavrogianni, Vasileios Giannopapas, Dimitrios K. Kitsos, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2630-2630
Open Access
The impact of disease modifying therapies on cognitive functions typically impaired in multiple sclerosis patients: a clinician’s review
Karolina Kania, Wojciech Ambrosius, Wojciech Kozubski, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 6
Karolina Kania, Wojciech Ambrosius, Wojciech Kozubski, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 6
Relevance of dedicated multiple sclerosis serum biomarkers in predicting contrast enhancement with gadolinium: Results from the REDUCE‐GAD trial
Jan Hendrik Schaefer, Martin Schaller, Katharina J. Wenger, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 8, pp. 2393-2400
Open Access | Times Cited: 3
Jan Hendrik Schaefer, Martin Schaller, Katharina J. Wenger, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 8, pp. 2393-2400
Open Access | Times Cited: 3
Cognitive and Neuropsychological Disorders in Patients with Multiple Sclerosis: A Focus on Verification and Diagnosis of Poorly Recognized Disease Symptoms (A Literature Review)
Fedulov As, К.В. Благочинная, А В Борисов
Неврология и нейрохирургия Восточная Европа (2023) Vol. 13, Iss. 2, pp. 219-242
Open Access
Fedulov As, К.В. Благочинная, А В Борисов
Неврология и нейрохирургия Восточная Европа (2023) Vol. 13, Iss. 2, pp. 219-242
Open Access
